These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 26518891)
1. Association of NOTCH with different microRNAs in head and neck cancer. Masood N; Qureshi MZ; Yasmin A Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):9-16. PubMed ID: 26518891 [TBL] [Abstract][Full Text] [Related]
2. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma. Fukusumi T; Califano JA J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439 [TBL] [Abstract][Full Text] [Related]
4. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs. Sun DW; Zhang HD; Mao L; Mao CF; Chen W; Cui M; Ma R; Cao HX; Jing CW; Wang Z; Wu JZ; Tang JH Cell Physiol Biochem; 2015; 37(5):1693-711. PubMed ID: 26545287 [TBL] [Abstract][Full Text] [Related]
5. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma. Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892 [TBL] [Abstract][Full Text] [Related]
7. Cancer. Another NOTCH for cancer. Brakenhoff RH Science; 2011 Aug; 333(6046):1102-3. PubMed ID: 21868662 [No Abstract] [Full Text] [Related]
8. Notch1 in oral squamous cell carcinoma. Yoshida R; Ito T; Hassan WA; Nakayama H Histol Histopathol; 2017 Apr; 32(4):315-323. PubMed ID: 27615693 [TBL] [Abstract][Full Text] [Related]
9. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma. Jing P; Sa N; Liu X; Liu X; Xu W Exp Mol Pathol; 2016 Feb; 100(1):132-8. PubMed ID: 26704053 [TBL] [Abstract][Full Text] [Related]
10. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma. Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392 [TBL] [Abstract][Full Text] [Related]
12. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc. Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504 [TBL] [Abstract][Full Text] [Related]
13. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Li Y; Zhang J; Zhang L; Si M; Yin H; Li J Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952 [TBL] [Abstract][Full Text] [Related]
14. Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer. Trinkaus ME; Hicks RJ; Young RJ; Peters LJ; Solomon B; Bressel M; Corry J; Fisher R; Binns D; McArthur GA; Rischin D J Med Imaging Radiat Oncol; 2014 Feb; 58(1):89-97. PubMed ID: 24529061 [TBL] [Abstract][Full Text] [Related]
15. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype. Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730 [TBL] [Abstract][Full Text] [Related]
16. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis. Zhao YY; Yu GT; Xiao T; Hu J Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
18. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma. Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105 [TBL] [Abstract][Full Text] [Related]
19. Suppression of microRNA-495 alleviates high-glucose-induced retinal ganglion cell apoptosis by regulating Notch/PTEN/Akt signaling. Zhang X; Yang Y; Feng Z Biomed Pharmacother; 2018 Oct; 106():923-929. PubMed ID: 30119264 [TBL] [Abstract][Full Text] [Related]
20. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma. Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]